Dr. Michele Gregorini
Founder and CEO
A PhD spent building all sort of devices, in particular this pyramid-shaped PCR machine that will change the way DNA analyses are performed!
Menu
Diaxxo AG, founded in 2020, is a spin-off of the Functional Materials Laboratory (FML) of ETH Zürich.
We envision a future where precise and reliable diagnostics can be accessed anywhere by anyone.
We believe that thanks to our Point-Of-Care PCR tests, doctors will be able to identify and fight diseases faster,
and experts will be able to perform much DNA analysis in a shorter time.
Our mission is to enable DNA analyses to be widely diffused and adopted by making them accurate, fast and affordable.
Quality is our priority. As your results are only as good as your detection technique.
Team work is our strenght and philosophy as it takes two flints to make a fire.
Passion is our driving force as nothing great can be accomplished without it.
It’s not about ideas. It’s about making ideas happen.
A PhD spent building all sort of devices, in particular this pyramid-shaped PCR machine that will change the way DNA analyses are performed!
DNA analysis is his thing. Philippe has made so many different test kits that he can now test anything!
Full Professor at ETH Zürich
The people that want to change the world with us.
The hardware guru! Edgar finds solutions to any problem you can think of.
Tobi has a long experience in DNA analysis gained in important institutions, especially in the field of infectious diseases.
Everyone can code these days. Viviane, instead, writes beautiful poems of 1s and 0s.
Luca brings our machines to life with the power of automation.
“Many receive advice, only the wise profit from it”
Former ThermoFisher, Prionics, Novartis
Hirslanden Zürich
Former Concretum
Former Biofire
Former Roche
diaxxoPod (RUO)
Our in-vitro diagnostic test cartridge based on rapid Polymerase Chain Reaction (PCR) amplification technology. This cartridge can reliably detect and distinguish the mutants from UK (20I/501Y.V1, B.1.1.7 – VOC-202012/01) as well as the South African mutation (B.1.351 lineage).
The test cartridge is aimed to improve the public health situation by rapidly enabling the detection of variants of concern. The cartridge is designed for qualitative detection of variants of interest of the SARS-CoV-2 Viral RNA in saliva samples and it works in conjuction with diaxxoPCR.
The test cartridges are sold with all the necessary reagents pre-loaded in the reaction wells. The use of the test cartridges is therefore extremely simple:
diaxxoPod
The test cartridges are sold with all the necessary reagents pre-loaded in the reaction wells. The use of the test cartridges is therefore extremely simple:
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
